(Updated - July 6, 2026 6:20 AM EDT)

Leerink analyst Andrew Berens initiates coverage on Parabilis Medicines (NASDAQ: PBLS) ...

This is a premium only article. To continue reading this and other premium stock market news articles please sign-in or upgrade to StreetInsider.com Premium below (Free Trial) LEARN MORE